Living-Donor Lung Transplantation for Post-COVID-19 Respiratory Failure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34748735.
- Also identified by DOI 10.1016/j.athoracsur.2021.10.003 and PMC identifier 8570407.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This report describes a case of coronavirus disease 2019 (COVID-19)-associated respiratory failure requiring urgent living-donor lobar lung transplantation (LDLLTx). Severe hypoxia requiring extracorporeal membrane oxygenation (ECMO) developed in a 57-year-old woman with positive viral status. Her respiratory function deteriorated, with almost totally collapsed lungs. All of her other organs functioned well. After 104 days of ECMO support, she underwent urgent LDLLTx using cardiopulmonary bypass. The grafts worked well, and she was weaned from cardiopulmonary bypass after reperfusion. LDLLTx is an option for selected patients with post-COVID-19 end-stage respiratory failure.
Medical subject headings
- COVID-19
- Extracorporeal Membrane Oxygenation
- Lung Transplantation
- Respiratory Insufficiency